149 related articles for article (PubMed ID: 37920380)
21. Invasive and Non-invasive Ductal Carcinoma within Malignant Phyllodes Tumour with Axillary Lymph Node Metastases.
Erdogan O; Parlakgumus A; Tas ZA; Yener K; Turan U
J Coll Physicians Surg Pak; 2022 Aug; 32(8):S92-S94. PubMed ID: 36210658
[TBL] [Abstract][Full Text] [Related]
22. Cystic hypersecretory lesions - invasive breast carcinoma-spectrum of a rare tumour.
Mitra S
Autops Case Rep; 2023; 13():e2023460. PubMed ID: 38034514
[No Abstract] [Full Text] [Related]
23. Metastatic Mammary Carcinoma Presenting as a Large Cystic Axillary Mass: A Report of an Unusual Case.
Maybank AK; Curtis H; Topp T; Barnes PJ
Int J Surg Pathol; 2023 Oct; 31(7):1409-1413. PubMed ID: 36803091
[TBL] [Abstract][Full Text] [Related]
24. Microinvasive breast cancer: pathological parameters, cancer subtypes distribution, and correlation with axillary lymph nodes invasion. Results of a large single-institution series.
Orzalesi L; Casella D; Criscenti V; Gjondedaj U; Bianchi S; Vezzosi V; Nori J; Cecconi L; Meattini I; Livi L; Bernini M
Breast Cancer; 2016 Jul; 23(4):640-8. PubMed ID: 25981971
[TBL] [Abstract][Full Text] [Related]
25. Cystic hypersecretory carcinoma: rare and poorly recognized variant of intraductal carcinoma of the breast. Report of five cases.
Skalova A; Ryska A; Kajo K; Di Palma S; Kinkor Z; Michal M
Histopathology; 2005 Jan; 46(1):43-9. PubMed ID: 15656885
[TBL] [Abstract][Full Text] [Related]
26. Cystic Hypersecretory Duct Carcinoma of the Breast:A Case Reprot Describing the Cytologic Features.
Moriya T; Ito J; Takasuga H; Okazaki K
Breast Cancer; 1996 Jun; 3(2):131-134. PubMed ID: 11091565
[TBL] [Abstract][Full Text] [Related]
27. Cystic hypersecretory ductal carcinoma of the breast: a rare cause of cystic breast mass.
Song SW; Whang IY; Chang ED
Jpn J Radiol; 2011 Nov; 29(9):660-2. PubMed ID: 21956373
[TBL] [Abstract][Full Text] [Related]
28. Cystic hypersecretory ductal carcinoma (CHDC): a rare distinctive variant of ductal carcinoma.
DiPasquale A; Peiris L; Silverman S
BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34289997
[TBL] [Abstract][Full Text] [Related]
29. Mammary adenoid cystic carcinoma presenting with Ductal carcinoma in situ and axillary lymph node metastasis.
Burusapat C; Buarabporn N; Wongchansom K; Chanapai P; Parinyanut P; Supaporn S
J Surg Case Rep; 2020 Feb; 2020(2):rjz362. PubMed ID: 32047591
[No Abstract] [Full Text] [Related]
30. Coexistence of pregnancy-like and cystic hypersecretory hyperplasia with invasive lobular carcinoma.
Takeuchi T; Tsuzuki H; Numoto S; Furihata M
Onkologie; 2011; 34(8-9):448-50. PubMed ID: 21934345
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ.
Magnoni F; Massari G; Santomauro G; Bagnardi V; Pagan E; Peruzzotti G; Galimberti V; Veronesi P; Sacchini VS
Br J Surg; 2019 Mar; 106(4):375-383. PubMed ID: 30791092
[TBL] [Abstract][Full Text] [Related]
32. Axillary Nodal Metastases in Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma: Comparison of Node Detection and Morphology by Ultrasound.
Chung HL; Tso HH; Middleton LP; Sun J; Leung JWT
AJR Am J Roentgenol; 2022 Jan; 218(1):33-41. PubMed ID: 34319162
[No Abstract] [Full Text] [Related]
33. Pathological controversies in breast cancer: classification of ductal carcinoma in situ, sentinel lymph nodes and low volume metastatic disease and reporting of neoadjuvant chemotherapy specimens.
Provenzano E; Brown JP; Pinder SE
Clin Oncol (R Coll Radiol); 2013 Feb; 25(2):80-92. PubMed ID: 23199579
[TBL] [Abstract][Full Text] [Related]
34. Intranodal papillary epithelial proliferations: a local process with a spectrum of morphologies and frequent association with papillomas in the breast.
Boulos FI; Granja NM; Simpson JF; O'Malley FP; Saadeldine MM; Page DL; Sanders ME
Am J Surg Pathol; 2014 Mar; 38(3):383-8. PubMed ID: 24525508
[TBL] [Abstract][Full Text] [Related]
35. The implications of a pathological complete response of the primary tumour after neoadjuvant chemotherapy for breast cancer on axillary surgery.
Youssef MMG; Metwally AA; Manie TM
J Egypt Natl Canc Inst; 2021 Feb; 33(1):5. PubMed ID: 33555499
[TBL] [Abstract][Full Text] [Related]
36. Extramedullary Haematopoiesis in Axillary Lymph Nodes of Breast Carcinoma Patients Receiving Neoadjuvant Chemotherapy: A Potential Diagnostic Pitfall.
Badr NM; Roberts C; Shaaban AM
Pathobiology; 2019; 86(2-3):167-172. PubMed ID: 30423570
[TBL] [Abstract][Full Text] [Related]
37. Metastatic "Ductal Carcinoma In Situ-Like" Lobular Carcinoma in a Lymph Node: A Case Report and Review of the Literature.
Tijani S; Sharma K; Yuen H; Shaaban A
Int J Surg Pathol; 2020 Jun; 28(4):436-439. PubMed ID: 31789065
[TBL] [Abstract][Full Text] [Related]
38. Cystic hypersecretory duct carcinoma of the breast. Report of a case with fine-needle aspiration.
Colandrea JM; Shmookler BM; O'Dowd GJ; Cohen MH
Arch Pathol Lab Med; 1988 May; 112(5):560-3. PubMed ID: 2833875
[TBL] [Abstract][Full Text] [Related]
39. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma.
Zekioglu O; Erhan Y; Ciris M; Bayramoglu H; Ozdemir N
Histopathology; 2004 Jan; 44(1):18-23. PubMed ID: 14717664
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of fine needle aspirates processed by ThinPrep® for the assessment of axillary lymph node status in patients with invasive carcinoma of the breast.
Jing X; Wey E; Michael CW
Cytopathology; 2013 Dec; 24(6):372-6. PubMed ID: 23020285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]